J. A. Mabe

732 total citations
25 papers, 534 citations indexed

About

J. A. Mabe is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, J. A. Mabe has authored 25 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Pharmacology and 8 papers in Organic Chemistry. Recurrent topics in J. A. Mabe's work include Microbial Natural Products and Biosynthesis (8 papers), Microbial metabolism and enzyme function (3 papers) and Cancer Treatment and Pharmacology (3 papers). J. A. Mabe is often cited by papers focused on Microbial Natural Products and Biosynthesis (8 papers), Microbial metabolism and enzyme function (3 papers) and Cancer Treatment and Pharmacology (3 papers). J. A. Mabe collaborates with scholars based in United States, Poland and New Zealand. J. A. Mabe's co-authors include Marvin Gorman, R. P. Elander, D. R. Brannon, Robert L. Hamill, Joel G. Whitney, Walter M. Nakatsukasa, Heinz G. Floss, D. S. Fukuda, C. CHANG and Lisandra L. Martin and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

In The Last Decade

J. A. Mabe

25 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. A. Mabe United States	13	300	204	140	93	55	25	534
Edward Inamine United States	15	410 1.4×	351 1.7×	162 1.2×	85 0.9×	70 1.3×	26	720
Jutta Kupka Germany	10	163 0.5×	209 1.0×	111 0.8×	62 0.7×	71 1.3×	10	395
Kazuhiko Kintaka Japan	8	193 0.6×	201 1.0×	240 1.7×	32 0.3×	36 0.7×	10	502
N. Bohonos China	16	363 1.2×	219 1.1×	187 1.3×	113 1.2×	56 1.0×	46	758
Tomoharu Okuda United States	17	309 1.0×	257 1.3×	297 2.1×	55 0.6×	51 0.9×	51	624
Hans‐Adolf Arfmann Germany	17	447 1.5×	115 0.6×	119 0.8×	108 1.2×	100 1.8×	40	694
Norio Ezaki United Kingdom	15	212 0.7×	247 1.2×	218 1.6×	53 0.6×	49 0.9×	25	503
Joseph J. Goodman United States	14	360 1.2×	181 0.9×	134 1.0×	50 0.5×	61 1.1×	35	616
HEINRICH H. PETER Switzerland	18	273 0.9×	266 1.3×	315 2.3×	59 0.6×	108 2.0×	34	786
Joel G. Whitney United States	9	198 0.7×	173 0.8×	194 1.4×	22 0.2×	23 0.4×	15	425

Countries citing papers authored by J. A. Mabe

Since Specialization

Citations

This map shows the geographic impact of J. A. Mabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. A. Mabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. A. Mabe more than expected).

Fields of papers citing papers by J. A. Mabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. A. Mabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. A. Mabe. The network helps show where J. A. Mabe may publish in the future.

Co-authorship network of co-authors of J. A. Mabe

This figure shows the co-authorship network connecting the top 25 collaborators of J. A. Mabe. A scholar is included among the top collaborators of J. A. Mabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. A. Mabe. J. A. Mabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fukuda, D. S., Jon S. Mynderse, Patrick J. Baker, et al.. (1990). A80915, a new antibiotic complex produced by Streptomyces aculeolatus. Discovery, taxonomy, fermentation, isolation, characterization, and antibacterial evaluation.. The Journal of Antibiotics. 43(6). 623–633. 51 indexed citations

Jones, Michael D., et al.. (1984). pFJ265, a new cloning vehicle for Streptomyces. Plasmid. 11(1). 92–95. 9 indexed citations

Richardson, Mark A., et al.. (1982). Development of cloning vehicles from the Streptomyces plasmid pFJ103. Gene. 20(3). 451–457. 31 indexed citations

Neuss, Norbert, Richard D. Miller, Walter M. Nakatsukasa, et al.. (1980). High Performance Liquid Chromatography (HPLC.) of Natural Products. III [1]. Isolation of New Tripeptides from the Fermentation Broth of P. Chrysogenum. Helvetica Chimica Acta. 63(5). 1119–1129. 8 indexed citations

Brannon, D. R., J. A. Mabe, & D. S. Fukuda. (1976). De-esterification of cephalosporin para-nitrobenzyl esters by microbial enzymes.. The Journal of Antibiotics. 29(2). 121–124. 10 indexed citations

Neuss, Norbert, et al.. (1974). Vinca Alkaloids XXXIII [1]. Microbiological Conversions of Vincaleukoblastine (VLB, Vinblastine), an Antitumor Alkaloid from Vinca rosea. LINN. Helvetica Chimica Acta. 57(6). 1886–1890. 11 indexed citations

Brannon, D. R., D. S. Fukuda, J. A. Mabe, F. M. Huber, & Joel G. Whitney. (1972). Detection of a Cephalosporin C Acetyl Esterase in the Carbamate Cephalosporin Antibiotic-Producing Culture, Streptomyces clavuligerus. Antimicrobial Agents and Chemotherapy. 1(3). 237–241. 8 indexed citations

Martin, Lisandra L., C. CHANG, Heinz G. Floss, et al.. (1972). Carbon-13 nuclear magnetic resonance study on the biosynthesis of pyrrolnitrin from tryptophan by Pseudomonas. Journal of the American Chemical Society. 94(25). 8942–8944. 21 indexed citations

Whitney, Joel G., et al.. (1972). Incorporation of Labeled Precursors into A16886B, a Novel β-Lactam Antibiotic Produced by Streptomyces clavuligerus. Antimicrobial Agents and Chemotherapy. 1(3). 247–251. 43 indexed citations

10.

Fukuda, D. S., J. A. Mabe, & D. R. Brannon. (1971). Production of Substituted l -Tryptophans by Fermentation. Applied Microbiology. 21(5). 841–843. 8 indexed citations

11.

Floss, Heinz G., et al.. (1971). Further studies on the biosynthesis of pyrrolnitrin from tryptophan by pseudomonas. Biochemical and Biophysical Research Communications. 45(3). 781–787. 10 indexed citations

12.

Brannon, D. R., J. A. Mabe, Bryan B. Molloy, & W. A. Day. (1971). Biosynthesis of dithiadiketopiperazine antibiotics: Comparison of possible aromatic amino acid precursors. Biochemical and Biophysical Research Communications. 43(3). 588–594. 11 indexed citations

13.

Elander, R. P., J. A. Mabe, Robert L. Hamill, & Marvin Gorman. (1971). Biosynthesis of pyrrolnitrins by analogue-resistant mutants ofPseudomonas fluorescens. Folia Microbiologica. 16(3). 156–165. 18 indexed citations

14.

Hamill, Robert L., R. P. Elander, J. A. Mabe, & Marvin Gorman. (1970). Metabolism of Tryptophan by Pseudomonas aureofaciens. Applied Microbiology. 19(5). 721–725. 14 indexed citations

15.

Hamill, Robert L., R. P. Elander, J. A. Mabe, & Marvin Gorman. (1970). Metabolism of Tryptophan by Pseudomonas aureofaciens. Applied Microbiology. 19(5). 721–725. 27 indexed citations

16.

Brannon, D. R., et al.. (1968). Fungal metabolism of some methyl dehydroabietanes. Chemical Communications (London). 681–681. 2 indexed citations

17.

Elander, R. P., et al.. (1968). Metabolism of Tryptophans by Pseudomonas aureofaciens. Applied Microbiology. 16(5). 753–758. 58 indexed citations

18.

Elander, R. P., et al.. (1968). Metabolism of Tryptophans by Pseudomonas aureofaciens. Applied Microbiology. 16(5). 753–758. 43 indexed citations

19.

Gorman, Marvin, Robert L. Hamill, R. P. Elander, & J. A. Mabe. (1968). Preparation of substituted phenyl pyrroles through the metabolism of tryptophan analogues. Biochemical and Biophysical Research Communications. 31(3). 294–298. 11 indexed citations

20.

Gorman, Marvin, et al.. (1966). Metabolism of tryptophans by Pseudomonas aureofaciens. I. Biosynthesis of pyrrolnitrin.. PubMed. 6. 462–9. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact